A study of mice fed a high-fat/high-fructose diet (designed to induce obesity) found that 12 weeks of treatment with low-dose psilocybin reduced weight gain, symptoms of fatty liver, hyperglycemia, ...

Updated Part B results demonstrated sustained efficacy for COMP360 psilocybin 25mg, maintaining symptom severity reductions through week 26 after just 1 or 2 doses.

Researchers led by Dr. Claire Foldi at Monash University have discovered that psilocybin, the psychoactive compound found in ...

Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience. Laura holds ...

A 2025 study found that mice given monthly doses of psilocybin over 10 months had an 80% survival rate (versus 50% in controls) and appeared physically younger, Researchers believe this may be due to ...

The company plans to meet with the FDA to discuss a rolling approval application for “COMP360,” a synthetic form of psilocybin that could become the first “classic” psychedelic cleared for the U.S.

A federally funded research initiative will enable researchers at Oregon Health & Science University and other organizations ...

Explore how psilocybin affects social behaviour and inflammation in female mice in groundbreaking research at Monash ...

In a recently published preprint study, entitled “Psilocybin desynchronizes brain networks,” researchers analyze the comparison between psilocybin and the default mode network (DMN) of the brain.

A new study shows that natural mushroom extracts may be more therapeutically effective than synthesized psilocybin, which is widely used in research investigating the medicinal potential of the ...